Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gotham Enhanced 500 ETF
GSPY
|
+$48.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$30.3M |
| 3 |
Exelon
EXC
|
+$17.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$17.3M |
| 5 |
PayPal
PYPL
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$10.3M |
| 2 |
Advanced Micro Devices
AMD
|
+$7.71M |
| 3 |
CERN
Cerner Corp
CERN
|
+$7.37M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$7.26M |
| 5 |
DTE Energy
DTE
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.88% |
| 3 | Industrials | 10.78% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Financials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
951
Dauch Corp
DCH
$1.63B
| $290K | 0.01% |
38,539
-3,135
| -8% | -$23.6K |
|
|
BPMC
952
DELISTED
Blueprint Medicines
BPMC
| $288K | 0.01% |
+5,694
| New | +$334K |
|
953
Brunswick
BC
$5.24B
| $287K | 0.01% |
4,383
| – | – |
|
954
Cinemark Holdings
CNK
$4.24B
| $287K | 0.01% |
19,079
+4,767
| +33% | +$75.5K |
|
955
OneMain Financial
OMF
$7.27B
| $284K | 0.01% |
7,597
-5,631
| -43% | -$243K |
|
956
Schneider National
SNDR
$6.28B
| $284K | 0.01% |
+12,687
| New | +$293K |
|
957
Cable One
CABO
$129M
| $282K | 0.01% |
+219
| New | +$279K |
|
958
East-West Bancorp
EWBC
$17.8B
| $282K | 0.01% |
4,352
+1,128
| +35% | +$81K |
|
959
Marcus & Millichap
MMI
$1.22B
| $282K | 0.01% |
7,624
+1,488
| +24% | +$64.7K |
|
960
Marten Transport
MRTN
$1.22B
| $282K | 0.01% |
+16,794
| New | +$289K |
|
961
Caesars Entertainment
CZR
$6.06B
| $280K | 0.01% |
7,304
-11,384
| -61% | -$634K |
|
962
Ligand Pharmaceuticals
LGND
$5.71B
| $280K | 0.01% |
5,038
-2,304
| -31% | -$131K |
|
963
Mercury Insurance
MCY
$5.85B
| $279K | 0.01% |
6,305
-3,814
| -38% | -$189K |
|
964
Travelers Companies
TRV
$75.8B
| $279K | 0.01% |
1,648
-983
| -37% | -$171K |
|
|
VGR
965
DELISTED
Vector Group Ltd.
VGR
| $277K | 0.01% |
26,393
-53,466
| -67% | -$642K |
|
966
Strategic Education
STRA
$1.85B
| $275K | 0.01% |
3,903
-1,167
| -23% | -$77.4K |
|
|
SMAR
967
DELISTED
Smartsheet Inc.
SMAR
| $274K | 0.01% |
+8,703
| New | +$361K |
|
968
Parsons
PSN
$5.24B
| $272K | 0.01% |
+6,730
| New | +$258K |
|
969
KeyCorp
KEY
$23.3B
| $270K | 0.01% |
15,691
-5,274
| -25% | -$102K |
|
970
Marqeta
MQ
$1.7B
| $264K | 0.01% |
+8,138
| New | +$320K |
|
971
PTC Therapeutics
PTCT
$5.83B
| $264K | 0.01% |
+6,599
| New | +$231K |
|
|
GDEN
972
DELISTED
Golden Entertainment
GDEN
| $263K | 0.01% |
6,647
-5,666
| -46% | -$267K |
|
973
Crocs
CROX
$5.85B
| $262K | 0.01% |
5,388
-16,845
| -76% | -$1.02M |
|
974
Smith & Wesson
SWBI
$632M
| $260K | 0.01% |
19,821
-19,615
| -50% | -$284K |
|
975
Addus HomeCare
ADUS
$2.26B
| $259K | 0.01% |
3,113
-1,578
| -34% | -$132K |
|
Similar funds
Joel Greenblatt's Q2 2022 Portfolio in Review
As of Q2 2022, Joel Greenblatt held 1,290 positions worth $3.11B, down 3.6% from $3.23B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Joel Greenblatt deployed $461M of net new capital in Q2 2022, opening 177 new positions and adding to 577 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 42,001 shares worth $15.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Eaton, an estimated $10.3M trimmed.
- Joel Greenblatt's largest Q2 2022 buy was iShares Core S&P 500 ETF: 42,001 shares worth $15.9M.
- Joel Greenblatt added most to Gotham Enhanced 500 ETF in Q2 2022, an estimated $48.7M increase.
- Joel Greenblatt's biggest Q2 2022 reduction was Eaton, cutting an estimated $10.3M.
- Joel Greenblatt fully exited Cerner Corp in Q2 2022, selling an estimated $7.37M.
- Joel Greenblatt's ten largest holdings make up 22% of its $3.11B portfolio in Q2 2022.
- Joel Greenblatt opened 177 new positions and closed 186 in Q2 2022.
- Joel Greenblatt's portfolio value fell 3.6% quarter-over-quarter to $3.11B.
Based on Gotham Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.